Capital M

Developing and Deploying COVID-19 Vaccines and Therapeutics

October 23, 2020 Maryland Tech Council Season 2 Episode 13
Capital M
Developing and Deploying COVID-19 Vaccines and Therapeutics
Chapters
Capital M
Developing and Deploying COVID-19 Vaccines and Therapeutics
Oct 23, 2020 Season 2 Episode 13
Maryland Tech Council

 Karen L. Smith, M.D., Ph.D., Executive Vice President, Chief Medical Officer of Emergent BioSolutions joined MTC CEO, Martin Rosendale for a discussion on developing and deploying COVID-19 vaccines and therapeutics. They discussed the supply chain and pipeline challenges, the value of collaboration in our region and Maryland as a premier vaccine industry cluster.

Show Notes

 Karen L. Smith, M.D., Ph.D., Executive Vice President, Chief Medical Officer of Emergent BioSolutions joined MTC CEO, Martin Rosendale for a discussion on developing and deploying COVID-19 vaccines and therapeutics. They discussed the supply chain and pipeline challenges, the value of collaboration in our region and Maryland as a premier vaccine industry cluster.